◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
ASKA Pharmaceutical Holdings Co.,Ltd. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022
+Revenue 64.1B 62.8B 60.5B 56.6B
Revenue Growth % 2.1% 3.9% 6.8% --
+Operating Income 5.3B 6.5B 5.1B 4.8B
Operating Margin % 8.3% 10.3% 8.4% 8.5%
Non Operating Income 398.0M 414.0M 433.0M 379.0M
Non Operating Expenses 622.0M 392.0M 308.0M 294.0M
Ordinary Income 5.1B 6.5B 5.2B 4.9B
Income Before Taxes 6.2B 9.9B 5.4B 6.2B
Income Taxes 1.1B 2.3B 1.1B 1.9B
+Net Income 5.1B 7.5B 4.2B 4.3B
Net Margin % 8.0% 12.0% 7.0% 7.6%
Eps 179.95 266.51 150.08 151.22
Depreciation Amortization 2.2B 2.7B 3.1B 2.9B
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022
Cash And Deposits 10.6B 13.7B 14.5B 12.1B
Current Assets 58.0B 56.1B 53.8B 49.6B
Property Plant Equipment 18.7B 11.3B 10.8B 10.9B
Noncurrent Assets 42.5B 34.6B 33.4B 33.7B
Total Assets 100.5B 90.7B 87.1B 83.3B
Current Liabilities 22.9B 24.0B 17.6B 16.0B
Total Liabilities 31.3B 28.8B 32.6B 34.4B
Retained Earnings 59.5B 56.4B 49.6B 45.8B
Total Equity 69.2B 61.9B 54.5B 48.9B
Equity Ratio 0.65 0.68 0.63 0.59
Book Value Per Share 2,303 2,186 1,928 1,735
Num Employees 1,632 762.00 747.00 777.00
Roe 0.08 0.13 0.08 0.09
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022
Operating Cash Flow 2.5B 1.5B 3.4B 2.8B
Investing Cash Flow -6.1B 1.7B -1.1B 6.7B
Financing Cash Flow -3.0B -3.9B -1.8B -3.0B
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...